Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Interest Expenses (2016)

Historic Interest Expenses for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$1507.0.

  • Tenax Therapeutics' Interest Expenses changed N/A to -$1507.0 in Q4 2016 from the same period last year, while for Sep 2017 it was -$1507.0, marking a year-over-year change of. This contributed to the annual value of $23000.0 for FY2024, which is 416.67% down from last year.
  • Tenax Therapeutics' Interest Expenses amounted to -$1507.0 in Q4 2016.
  • Tenax Therapeutics' 5-year Interest Expenses high stood at $44.0 million for Q2 2013, and its period low was -$39.7 million during Q2 2012.
  • Moreover, its 4-year median value for Interest Expenses was $844650.5 (2012), whereas its average is $1.6 million.
  • The largest annual percentage gain for Tenax Therapeutics' Interest Expenses in the last 5 years was 1249641.71% (2012), contrasted with its biggest fall of 3249208.82% (2012).
  • Over the past 4 years, Tenax Therapeutics' Interest Expenses (Quarter) stood at $867524.0 in 2012, then skyrocketed by 4967.53% to $44.0 million in 2013, then tumbled by 99.99% to $2345.0 in 2015, then plummeted by 164.26% to -$1507.0 in 2016.
  • Its Interest Expenses stands at -$1507.0 for Q4 2016, versus $2345.0 for Q2 2015 and $44.0 million for Q2 2013.